Repligen Investor Presentation March 2022

Repligen is a bioprocessing solutions provider offering differentiated, single-use technologies for biological drug manufacturing. The company reported $671M in 2021 revenue with 45% growth, driven by innovation and market leadership in the expanding biologics sector with an $8B+ TAM.